Technology
Gradient Denervation Technologies Appoints Stanton Rowe To Board Of Directors And Receives FDA Approval To Expand Early Feasibility Study
(MENAFN - GlobeNewsWire - Nasdaq) Serial entrepreneur and medical device industry executive adds key experience to board of directorsPARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation ...
By: menafn
- Oct 22 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS